Loading...
Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function
The irreversible Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has shown efficacy against B-cell tumors such as chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma. Fcγ receptors (FcγR) on immune cells such as macrophages play an important role in tumor-specific antibody-mediated...
Na minha lista:
| Udgivet i: | J Biol Chem |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Biochemistry and Molecular Biology
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4742765/ https://ncbi.nlm.nih.gov/pubmed/26627823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M115.687251 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|